Pratley RE, Aroda VR, Lingvay I, Ldemann J, Andreassen C, Navarria A et al (2018) Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
The right approach depends on your practice size, specialty, PA volume, and budget
In large-scale, placebo-controlled trials of Wegovy, people have lost around 15% of their weight, well above the average weight loss seen with diet and exercise or with older obesity drugs
This allows us to determine if youre a good fit for this program
Mariam Malik, who treats patients at SKN Cosmetics Clinic in Islamabad